Group 1 - The core viewpoint of the article is that Hongchang Technology is accelerating its expansion into the humanoid robot industry chain through increased investment in Guangdong Liangzhi Joint Technology Co., Ltd. [1] - Hongchang Technology plans to invest an additional 15 million yuan in Liangzhi Joint, raising its stake from 15% to 30% [1][2] - Liangzhi Joint, established in September 2024, specializes in the research and production of high-precision harmonic reducers and planetary joints, with applications in humanoid robots and collaborative robots [1][2] Group 2 - In the first four months of 2025, Liangzhi Joint reported revenue of 875,400 yuan and a net loss of 255,500 yuan, with total assets of 18.31 million yuan and net assets of 17.67 million yuan as of April 30, 2025 [2] - Hongchang Technology aims to leverage its existing home appliance and automotive parts businesses to seek external development opportunities and accelerate the expansion of the humanoid robot industry chain [2] - A joint venture named Hangzhou Hongzhi Motor Technology Co., Ltd. is planned, with Hongchang Technology investing 7 million yuan for a 70% stake and Liangzhi Joint investing 3 million yuan for a 30% stake [2] Group 3 - Hongchang Technology, established in 1996, is a high-tech enterprise engaged in R&D, production, and sales, primarily in the fields of home appliances and automotive components [3] - In the first quarter of 2025, Hongchang Technology achieved revenue of 270 million yuan, a year-on-year increase of 23.22%, but its net profit decreased by 26.07% to 11.93 million yuan [3] - The company's gross margin fell to 14.66%, marking the lowest level for the same period in the past six years [3]

5月以来，A股并购重组呈现多点开花的局面。一方面，已发布重组预案的公司有序推进并购进程，受 理、问询进度备受关注；另一方面，新增并购案例层出不穷，交易模式偏向以现金为主的"短平快"，并 购方向则看向以产业协同为首的新兴产业、未来产业。 上证报记者关注到，仅5月13日一天，就有十多家上市公司密集发布并购重组相关公告，其中近半数是 首次宣布并购计划。从交易方式来看，现金收购成为更多上市公司的首选，不少公司以小额参股、增资 等形式获得相关标的公司股权，个别涉及控股权的收购仍以现金及发行股份相结合的方式进行。从并购 目的来看，产业协同仍是主流趋势，既有横向整合扩展市场，也有垂直整合完善产业链条。 "并购重组蕴含着方案设计、标的对接与多方博弈的独特魅力，当前众多潜在项目正处于关键推进阶 段。"民生证券投行业务部经理项捷克对记者表示，在"并购六条"引导下，上市公司通过产业整合提升 竞争力、央国企加速资源优化配置，企业发展的内生动力正成为推动并购市场持续升温的核心引擎，预 示着未来并购市场将持续保持火热态势。 现金并购频现交易便捷性受青睐 据不完全统计，5月13日，至少有15家A股公司披露了并购重组相关公告，其中有7家公司 ...

Group 1 - Shengyi Electronics plans to repurchase shares with a total amount between 50 million and 100 million yuan, at a price not exceeding 43.02 yuan per share, for employee stock ownership plans [1] - Guoyao Modern's subsidiary has passed the consistency evaluation for the quality and efficacy of a generic drug, which is used for treating severe infections [1] - Tianhe Magnetic Materials' subsidiaries have obtained project filing notices for high-performance rare earth permanent magnet projects, with total investments of 100 million yuan and 50 million yuan respectively [1][2] Group 2 - Dream Lily intends to repurchase shares with an amount between 85 million and 170 million yuan, at a price not exceeding 10.90 yuan per share, supported by a loan commitment of up to 150 million yuan [3] - Weifu High-Tech has received a loan commitment of up to 135 million yuan from a financial institution for share repurchase [3] Group 3 - Lu'an Environmental Energy reported a coal sales volume of 4.51 million tons in April, a year-on-year increase of 17.75% [5] - *ST Tianshan reported a significant decline in livestock sales and revenue, with a revenue of 70,500 yuan in April, down 95.68% year-on-year [7] Group 4 - Feirongda announced a cash dividend of 0.38 yuan per 10 shares, with a total distribution of 21.9 million yuan [8] - Zhejiang Rongtai's shareholders and executives plan to reduce their holdings by up to 1.93% of the company's shares [9] Group 5 - Changhua Group's subsidiary won the land use rights for an industrial site in Ningbo for 27.05 million yuan, intended for manufacturing and related business [11] - Zejing Pharmaceutical's new drug application for a treatment for severe alopecia has been accepted by the regulatory authority [13][14] Group 6 - Hainan Mining plans to distribute a cash dividend of 0.8 yuan per 10 shares, totaling 1.59 billion yuan [15] - China Jushi plans to distribute a cash dividend of 0.24 yuan per share, totaling 9.61 billion yuan [16] Group 7 - Zhengzhong Design's subsidiary has obtained a utility model patent for an acrylic signage guide [18] - Rundu Co., Ltd. received approval for a veterinary drug product, which is intended for treating bacterial diseases in livestock [20] Group 8 - Emei Mountain A announced the resignation of its general manager due to work reasons [22] - Tonghua Dongbao's insulin injection has received a registration certificate in Nicaragua, allowing for sales in that market [23] Group 9 - Dizu Fashion's subsidiary has completed the registration of a private equity investment fund [24] - Ningbo Gaofa plans to increase capital by 60 million yuan in its subsidiary for operational needs [26] Group 10 - Haichuan Intelligent has obtained two utility model patents for material handling devices [27] - Newland's subsidiary signed a deep cooperation agreement with Alibaba Cloud for AI model applications [29] Group 11 - Rui Neng Technology's controlling shareholder plans to reduce its stake by up to 2.89% [30] - Guomai Culture intends to repurchase shares between 50 million and 100 million yuan for capital reduction [31] Group 12 - Shaanxi Construction won major construction projects totaling 7.88 billion yuan in April [32] - Hanyu Pharmaceutical signed a joint development agreement for a new peptide drug with a partner [34] Group 13 - Yunnan Copper is planning to acquire a 40% stake in Liangshan Mining, leading to a stock suspension [35] - Haizheng Pharmaceutical plans to repurchase shares between 50 million and 100 million yuan for employee stock ownership [36] Group 14 - Tianqiao Hoisting's controlling shareholder plans to increase its stake by 75 million to 150 million yuan [37] - Tiandi Online's controlling shareholder is transferring shares to introduce a strategic investor [38] Group 15 - Hongchang Technology plans to invest 15 million yuan in a joint venture with a partner [39] - Rabbit Baby's subsidiary is preparing for an IPO in Hong Kong [41] Group 16 - Wol Nuclear Materials is planning to issue H-shares for listing in Hong Kong [42] - Tangyuan Electric plans to raise up to 864 million yuan through a private placement for various projects [43] Group 17 - Tongrun Equipment's major shareholders plan to reduce their holdings by up to 2% [44] - Linzhou Heavy Machinery plans to raise up to 600 million yuan through a private placement [46] Group 18 - China Merchants Securities announced the resignation of its vice president [47] - Shangsheng Electronics plans to issue convertible bonds to raise up to 330 million yuan for various projects [48] Group 19 - Longda Co., Ltd.'s major shareholder plans to reduce its stake by up to 1% [49] - China Medical plans to acquire 100% of Jinsui Technology for 302 million yuan [50] Group 20 - Silek has signed a strategic cooperation agreement with a battery manufacturer [51] - Boyun New Materials' major shareholder plans to reduce its stake by up to 3% [53]

Industry Overview - The humanoid robot industry is experiencing rapid growth, with significant interest and investment from various companies and sectors [2][3] - Major companies are actively engaging in partnerships and collaborations to enhance the development and application of humanoid robots [3][4] Company Activities - Hongchang Technology plans to invest 15 million yuan in Guangdong Liangzhi Joint Technology Co., focusing on the humanoid robot supply chain [2] - Songyan Power has launched a new generation of bionic robots, showcasing advanced features and achieving over 1,000 units in pre-orders [3] - ChaoYin Co. and Guodi Center have signed a cooperation agreement to advance resource integration and technology collaboration in urban service scenarios [3] Market Sentiment - Industry leaders express optimism about the humanoid robot market, with many companies reporting a surge in orders [2] - The market is expected to accelerate significantly, with predictions that 2025 could mark the year of mass production for humanoid robots [3] Technological Development - The humanoid robot sector is transitioning from experimental phases to practical applications, with ongoing advancements in key technologies [4][5] - Companies are focusing on improving the performance and cost-effectiveness of humanoid robots, with innovations in lightweight materials and intelligent software [5]

Company Announcements - Zhaowei Electromechanical plans to reduce its shareholding by no more than 1.5%, equating to approximately 3.6 million shares [1] - China CNR Corporation has signed several major contracts totaling approximately 54.74 billion yuan, representing about 22.2% of its expected revenue for 2024 [2] - Yunnan Copper is planning to acquire a 40% stake in Liangshan Mining, leading to a temporary suspension of its stock [2] - Sunshine Nuohua intends to acquire 100% of Langyan Life, with its stock set to resume trading [3] - Wolong Materials is planning to issue H-shares and apply for a listing on the Hong Kong Stock Exchange [3] - Hanyu Pharmaceutical has signed a joint development agreement for a novel peptide drug targeting metabolic diseases [3] - Lijun Co. confirms that its operations are normal and there are no undisclosed significant matters [3] Investments & Acquisitions - China Medical plans to acquire 100% of Jinsui Technology for 302 million yuan [4] - Shuangyi Technology intends to acquire 100% of Marky Industries for 18 million AUD, along with specific assets [5] Strategic Partnerships - Sileck has signed a strategic cooperation agreement with Lihua Power for the development of large cylindrical batteries [6] - Hongchang Technology plans to invest 15 million yuan in a humanoid robot industry chain company [7] - Macroview Technology is establishing a wholly-owned subsidiary focused on artificial intelligence [8] - Yihua Jiaye has signed a strategic cooperation framework agreement with Hanyu Pharmaceutical and Hanyu Health to develop a sleep health ecosystem [9] - Wanda Film is investing in Lezi Tiancheng and will engage in strategic cooperation in IP toy product development [10] Shareholding Changes - Tiandi Online's controlling shareholder is transferring 6.97% of its shares to introduce a strategic investor [12] - Longjiang Transportation plans to reduce its shareholding by no more than 3% [13] - Boyun New Materials intends to reduce its shareholding by no more than 3% [14] - Tongrun Equipment's major shareholder plans to reduce its stake by no more than 2% [15] Financing & Capital Increase - Tangyuan Electric plans to raise no more than 864 million yuan through a private placement [16] - Shangsheng Electronics intends to issue convertible bonds to raise up to 330 million yuan [17] Other Developments - Xianju Pharmaceutical has obtained a domestic production registration certificate for Dydrogesterone tablets [18] - Rongchang Bio has received a clinical trial application acceptance notice for its antibody-drug conjugate RC278 [19] - Jiangsu Leili's subsidiary Dingzhi Technology is implementing a stock incentive plan [20]

根据公司发展战略，公司拟以现有家电零部件业务和汽车零部件业务为基础，积极寻求外延式发展机 会，加速拓展人形机器人产业链相关业务，发展新的利润增长点。良质关节为公司2025年年初投资的参 股公司，本次增资前持股比例15%，良质关节是一家聚焦人形机器人相关产业链领域，主要从事谐波减 速器、行星减速器及关节模组研发、生产、销售的公司。2025年年初增资以来，人形机器人产业链及外 骨骼相关产业快速发展，良质关节与下游客户积极对接，目前与部分人形机器人公司和外骨骼公司签署 了或正在签署相关业务合作协议，鉴于对上述产业链的持续看好，公司拟加大对良质关节的投资并与良 质关节成立合资公司继续加大对相关产业链的投资，本次增资完成后公司投资良质关节合计3,000万 元，持股比例30%。同时拟与良质关节成立合资公司拓展电机及关节模组相关零部件业务。 格隆汇5月12日丨宏昌科技(301008.SZ)公布，浙江宏昌电器科技股份有限公司根据公司发展战略，以公 司现有家电零部件业务和汽车零部件业务为基础，寻求外延式发展机会，加速拓展人形机器人产业链相 关业务，发展新的利润增长点，拟使用自有资金对外投资。具体情况如下：（1）公司拟与广东良质 ...

| 证券代码：301008 | 证券简称：宏昌科技 | 公告编号：2025-058 | | --- | --- | --- | | 债券代码：123218 | 债券简称：宏昌转债 | | 浙江宏昌电器科技股份有限公司 关于 2024 年度权益分派调整可转债转股价格的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，不存在任 何虚假记载、误导性陈述或者重大遗漏。 特别提示： 1. 债券代码：123218 债券简称："宏昌转债" 一、转股价格调整依据 经中国证券监督管理委员会（以下简称"中国证监会"）《关于同意浙江宏昌 电器科技股份有限公司向不特定对象发行可转换公司债券注册的批复》（证监许 可[2023]1057 号）同意注册，公司于 2023 年 8 月 10 日向不特定对象发行 380.00 万张可转换公司债券，每张面值 100 元，发行总额 38,000.00 万元。根据《浙江 宏昌电器科技股份有限公司创业板向不特定对象发行可转换公司债券募集说明 书》（以下简称"《募集说明书》"）的相关条款，以及中国证券监督管理委员会会 （以下简称"中国证监会"）关于公开发行可转换公司债券的有关规定，"宏昌转 ...

| 证券代码：301008 | 证券简称：宏昌科技 | 公告编号：2025-056 | | --- | --- | --- | | 债券代码：123218 | 债券简称：宏昌转债 | | 浙江宏昌电器科技股份有限公司 关于公司对外投资暨关联交易的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，不存在任 何虚假记载、误导性陈述或者重大遗漏。 重要提示： 1、浙江宏昌电器科技股份有限公司（以下简称"公司"）拟通过增资1,500万 元的方式投资广东良质关节科技有限公司（以下简称"良质关节"），投资完成后 持有该公司30%的股权。 2、公司拟与良质关节共同投资成立合资公司，其中公司出资700万元，良质 关节出资300万元，投资完成后公司持有该合资公司70%的股权，良质关节持有 该合资公司30%的股权。 3、根据《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公 司自律监管指引第2号-创业板上市公司规范运作》《公司章程》《对外投资管理 制度》《关联交易管理制度》等相关规定，本次对外投资事项经公司第三届董事 会第三次会议审议通过，因公司董事、副总经理、董事会秘书佘砚先生为该公司 董事，本次交易事项 ...

| 证券代码：301008 | 证券简称：宏昌科技 | 公告编号：2025-055 | | --- | --- | --- | | 债券代码：123218 | 债券简称：宏昌转债 | | 浙江宏昌电器科技股份有限公司 第三届董事会第三次会议决议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 浙江宏昌电器科技股份有限公司（以下简称"公司")第三届董事会第三次会议 于2025年5月9日以现场及通讯表决的方式召开。会议通知于2025年5月6日发出。 会议由公司董事长陆宝宏先生召集并主持，应到董事8人，实到董事8人，公司高 级管理人员列席了会议。会议的召集、召开和表决程序符合《中华人民共和国公 司法》等法律、法规和《公司章程》的有关规定。 二、董事会会议审议情况 1、以7票同意、0票反对、0票弃权，审议通过了《关于公司对外投资暨关联 交易的议案》。 因公司董事、副总经理、董事会秘书佘砚先生为该公司董事本次交易事项构 成关联交易，审议时佘砚先生已回避表决。该事项无需提交公司股东会审议，不 构成《上市公司重大资产重组管理办法》规定的重大资产 ...

| 证券代码：301008 | 证券简称：宏昌科技 | 公告编号：2025-057 | | --- | --- | --- | | 债券代码：123218 | 债券简称：宏昌转债 | | 浙江宏昌电器科技股份有限公司 【注：根据先进先出的原则，以投资者证券账户为单位计算持股期限，持股1个 月（含1个月）以内，每10股补缴税款0.200000元；持股1个月以上至1年（含1年） 的，每10股补缴税款0.100000元；持股超过1年的，不需补缴税款。】 二、股权登记日与除权除息日 本次权益分派股权登记日为：2025年5月16日，除权除息日为：2025年5月19 日。 三、权益分派对象 关于 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，不存在任 何虚假记载、误导性陈述或者重大遗漏。 浙江宏昌电器科技股份有限公司（以下简称"公司"）关于2024年年度权益 分派预案已获2025年4月21日召开的2024年度股东大会审议通过，现将权益分派 事宜公告如下： 一、权益分派方案 本公司2024年年度权益分派方案为：以公司现有总股本剔除已回购股份 1,200,000.00股后的112 ...